Risks in estimating risk

European Heart Journal

Volumn 35, Issue 9, 2014, Pages

  Graham, Ian M ^a,b   Cooney, Marie Therese ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Charlemont Clinic   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CZECH REPUBLIC; DECISION SUPPORT SYSTEM; EATING; EDITORIAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LITHUANIA; POLAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; RUSSIAN FEDERATION; SCORING SYSTEM; SMOKING;

ATHEROSCLEROSIS; FEMALE; HUMANS; MALE;

EID: 84895895573     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht286     Document Type: Editorial

References (32)

1. Vikhireva O, Pajak A, Broda G, Malyutina S, Tamosiunas A, Kubinova R, Simonova G, Skodova Z, Bobak M, Pikhart H. SCOREperformance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results. Eur Heart J 2014;35: 571-577.
2. Cooney M, Dudina A, Graham IM, for the SCORE investigators. SCORE ELD-Extending risk estimation to older people. Eur Heart J 2009;29(Suppl):266- 2677.
3. World Health Organisation. www.who.int.
4. Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, Feely J, Capewell S. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health 2006;60:322-327.
5. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, Between 1982 and 1993. Circulation 2000;102:1511-1516.
6. Ford E, Ajani U, Croft J, Critchley J, Labarthe D, Kottke T, Giles W, Capewell S. Explaining the decrease in U.S deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398.
7. Laatikainen L, Critchley J, Vartiainen E, SalomaaV, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005;162:764-773.
8. Unal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109: 1101-1107.
9. Perk J,DeBacker G, Gohlke H, GrahamI, Reiner Z, VerschurenM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, Cooney MT, Bax J, Baumgartner H, Ceconi C, Dean V, Fagard R, Funck-Brentano C, Hasdai D, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Aboyans V, Ezquerra EA, Baigent C, Brotons C, Burell G, Ceriello A, De Sutter J, Deckers J, Del Prato S, Diener HC, Fitzsimons D, Fras Z, Hambrecht R, Jankowski P, Keil U, Kirby M, Larsen ML, Mancia G, Manolis AJ, McMurray J, Pajak A, Parkhomenko A, Rallidis L, Rigo F, Rocha E, Ruilope LM, van der Velde E, Vanuzzo D, Viigimaa M, Volpe M, Wiklund O, Wolpert C. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-1701.
10. Lindman AS, Veierod MB, Pedersen JI, Tverdal A, Njolstad I, Selmer R. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Eur J Cardiovasc Prev Rehabil 2007;14:501-507.
11. van Dis I, Kromhout D, Geleijnse JM, Boer JM, VerschurenWM.Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example. Eur J Cardiovasc Prev Rehabil 2010;17:244-249.
12. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A,Witteman JC. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med 2003;163:1323-1328.
13. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, PatschW. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, andHDLdensity subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108-1113.
14. Cooney MT, Dudina A, D'Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 2010;122:300-310.
15. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009;54: 1209-1227.
16. Allan G, Nouri F, KorownykC, Kolber MR,Vandermeer B,McCormack J. Agreement among cardiovascular disease risk calculators. Circulation 2013;127:1929-1931.
17. Jackson R, Kerr A, Wells S. Vascular risk calculators: essential but flawed clinical tools? Circulation 2013;127:1929-1931.
18. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-753.
19. Conroy RM, Pyorala K, FitzgeraldAP, Sans S, Menotti A,DeBacker G,DeBacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A,Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
20. Liu J, Hong Y, D'Agostino RB Sr., Wu Z,WangW, Sun J, Wilson PW, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004;291:2591-2599.
21. Panagiotakos DB, Fitzgerald AP, Pitsavos C, Pipilis A, Graham I, Stefanadis C. Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project). Hellenic J Cardiol 2007;48: 55-63.
22. Hense HW, Koesters E,Wellmann J, Meisinger C, Volzke H, Keil U. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany. Eur J Cardiovasc Prev Rehabil 2008;15:409-415.
23. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136.
24. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, Sega R, Pilotto L, Palmieri L, Giampaoli S. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005;34:413-421.
25. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007;93:172-176.
26. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187.
27. Hippisley-CoxJ, Coupland C, VinogradovaY, RobsonJ, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-1482.
28. Kerr AJ, Broad J,Wells S, Riddell T, Jackson R. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart 2009;95: 125-129.
29. Cooney MT, Vartiainen E, Laatikainen T, De Bacquer D, McGorrian C, Dudina A, Graham I. Cardiovascular risk age: concepts and practicalities. Heart 2012;98: 941-946.
30. Cuende JI, Cuende N, Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. Eur Heart J 2010;31:2351-2358.
31. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14 Suppl 2:S1-113.
32. HeartScore. www.HeartScore.org (30 October 2013).